PubMed:10229324
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 38-72 | protein | denotes | IL-2R associated JAK/STAT proteins |
| T2 | 81-138 | cell_line | denotes | HTLV-I(+), IL-2-independent and IL-2-dependent cell lines |
| T3 | 143-168 | cell_type | denotes | uncultured leukemic cells |
| T4 | 258-263 | protein | denotes | IL-2R |
| T5 | 276-284 | protein | denotes | Jak/STAT |
| T6 | 301-322 | cell_line | denotes | HTLV-I infected cells |
| T7 | 364-368 | protein | denotes | Jak3 |
| T8 | 370-375 | protein | denotes | STAT3 |
| T9 | 381-386 | protein | denotes | STAT5 |
| T10 | 398-420 | cell_line | denotes | HTLV-I(+) T-cell lines |
| T11 | 428-455 | cell_type | denotes | uncultured leukemic T cells |
| T12 | 561-565 | protein | denotes | Jak3 |
| T13 | 580-585 | protein | denotes | STAT3 |
| T14 | 590-595 | protein | denotes | STAT5 |
| T15 | 621-648 | cell_line | denotes | IL-2-independent cell lines |
| T16 | 682-707 | cell_line | denotes | IL-2-dependent cell lines |
| T17 | 769-773 | protein | denotes | Jak3 |
| T18 | 778-783 | protein | denotes | STAT5 |
| T19 | 791-805 | cell_type | denotes | leukemic cells |
| T20 | 880-884 | protein | denotes | IL-2 |
| T21 | 897-901 | protein | denotes | Jak3 |
| T22 | 906-911 | protein | denotes | STAT5 |
| T23 | 936-955 | cell_type | denotes | leukemic ATLL cells |
| T24 | 960-980 | cell_line | denotes | IL-2-dependent lines |
| T25 | 1009-1026 | protein | denotes | SHP-1 phosphatase |
| T26 | 1060-1077 | protein | denotes | cytokine receptor |
| T27 | 1106-1133 | cell_line | denotes | IL-2 independent cell lines |
| T28 | 1164-1174 | cell_type | denotes | ATLL cells |
| T29 | 1195-1217 | cell_line | denotes | HTLV-I(+) T-cell lines |
| T30 | 1245-1267 | cell_line | denotes | HTLV-I(-) T-cell lines |
| T31 | 1424-1428 | protein | denotes | Jak3 |
| T32 | 1430-1435 | protein | denotes | STAT3 |
| T33 | 1441-1446 | protein | denotes | STAT5 |
| T34 | 1568-1572 | protein | denotes | IL-2 |
| T35 | 1600-1605 | protein | denotes | IL-2R |
| T36 | 1606-1614 | protein | denotes | Jak/STAT |
| T37 | 1723-1728 | protein | denotes | SHP-1 |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-219 | Sentence | denotes | Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia. |
| S2 | 220-522 | Sentence | denotes | To determine activation status of the IL-2R-associated (Jak/STAT) pathway in the HTLV-I infected cells, we examined tyrosine phosphorylation of Jak3, STAT3, and STAT5 in several HTLV-I(+) T-cell lines and in uncultured leukemic T cells isolated from patients with adult T-cell lymphoma/leukemia (ATLL). |
| S3 | 523-708 | Sentence | denotes | Constitutive basal phosphorylation of Jak3 and, usually, STAT3 and STAT5 was detected in all four IL-2-independent cell lines tested, but in none of the three IL-2-dependent cell lines. |
| S4 | 709-853 | Sentence | denotes | Similarly, there was no detectable basal phosphorylation of Jak3 and STAT5 in the leukemic cells from ATLL patients (0/8 and 0/3, respectively). |
| S5 | 854-981 | Sentence | denotes | However, stimulation with IL-2 resulted in Jak3 and STAT5 phosphorylation in both leukemic ATLL cells and IL-2-dependent lines. |
| S6 | 982-1181 | Sentence | denotes | Furthermore, expression of SHP-1 phosphatase which is a negative regulator of cytokine receptor signaling, was lost in most IL-2 independent cell lines (3/4) but not in the leukemic ATLL cells (0/3). |
| S7 | 1182-1321 | Sentence | denotes | Finally, the HTLV-I(+) T-cell lines (313) but not the control, HTLV-I(-) T-cell lines were resistant to rapamycin and its novel analog RAD. |
| S8 | 1322-1772 | Sentence | denotes | We conclude that (1) HTLV-I infection per se does not result in a constitutive phosphorylation of the Jak3, STAT3, and STAT5 proteins; (2) malignant transformation in at least some cases of ATLL does not require the constitutive, but may require IL-2-induced, activation of the IL-2R Jak/STAT pathway; and (3) there are major differences in T-cell immortalization mechanism(s) which appear to involve SHP-1 and target molecules for rapamycin and RAD. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 188-218 | NP | denotes | adult T-cell lymphoma/leukemia |
| C1 | 174-218 | NP | denotes | patients with adult T-cell lymphoma/leukemia |
| C3 | 254-293 | NP | denotes | the IL-2R-associated (Jak/STAT) pathway |
| C5 | 364-368 | NP | denotes | Jak3 |
| C6 | 370-375 | NP | denotes | STAT3 |
| C7 | 381-386 | NP | denotes | STAT5 |
| C4 | 364-386 | NP | denotes | Jak3, STAT3, and STAT5 |
| C9 | 484-521 | NP | denotes | adult T-cell lymphoma/leukemia (ATLL) |
| C8 | 470-521 | NP | denotes | patients with adult T-cell lymphoma/leukemia (ATLL) |
| C10 | 561-565 | NP | denotes | Jak3 |
| C11 | 580-585 | NP | denotes | STAT3 |
| C12 | 590-595 | NP | denotes | STAT5 |
| C13 | 769-773 | NP | denotes | Jak3 |
| C14 | 778-783 | NP | denotes | STAT5 |
| C16 | 811-824 | NP | denotes | ATLL patients |
| C15 | 787-824 | NP | denotes | the leukemic cells from ATLL patients |
| C17 | 1009-1026 | NP | denotes | SHP-1 phosphatase |
| C18 | 1027-1032 | NP | denotes | which |
| C19 | 1151-1174 | NP | denotes | the leukemic ATLL cells |
| C20 | 1232-1243 | NP | denotes | the control |
| C21 | 1245-1267 | NP | denotes | HTLV-I(-) T-cell lines |
| C23 | 1286-1295 | NP | denotes | rapamycin |
| C24 | 1300-1303 | NP | denotes | its |
| C22 | 1286-1320 | NP | denotes | rapamycin and its novel analog RAD |
| C25 | 1420-1456 | NP | denotes | the Jak3, STAT3, and STAT5 proteins; |
| C26 | 1512-1516 | NP | denotes | ATLL |
| C27 | 1596-1623 | NP | denotes | the IL-2R Jak/STAT pathway; |
| C28 | 1663-1698 | NP | denotes | T-cell immortalization mechanism(s) |
| C29 | 1699-1704 | NP | denotes | which |
| C31 | 1754-1763 | NP | denotes | rapamycin |
| C30 | 1754-1771 | NP | denotes | rapamycin and RAD |
| R1 | C9 | C2 | coref-ident | adult T-cell lymphoma/leukemia (ATLL),adult T-cell lymphoma/leukemia |
| R2 | C8 | C1 | coref-ident | patients with adult T-cell lymphoma/leukemia (ATLL),patients with adult T-cell lymphoma/leukemia |
| R3 | C10 | C5 | coref-ident | Jak3,Jak3 |
| R4 | C11 | C6 | coref-ident | STAT3,STAT3 |
| R5 | C12 | C7 | coref-ident | STAT5,STAT5 |
| R6 | C13 | C10 | coref-ident | Jak3,Jak3 |
| R7 | C14 | C12 | coref-ident | STAT5,STAT5 |
| R8 | C16 | C8 | coref-ident | ATLL patients,patients with adult T-cell lymphoma/leukemia (ATLL) |
| R9 | C18 | C17 | coref-relat | which,SHP-1 phosphatase |
| R10 | C19 | C15 | coref-ident | the leukemic ATLL cells,the leukemic cells from ATLL patients |
| R11 | C21 | C20 | coref-appos | HTLV-I(-) T-cell lines,the control |
| R12 | C24 | C23 | coref-pron | its,rapamycin |
| R13 | C25 | C4 | coref-ident | "the Jak3, STAT3, and STAT5 proteins;","Jak3, STAT3, and STAT5" |
| R14 | C26 | C9 | coref-ident | ATLL,adult T-cell lymphoma/leukemia (ATLL) |
| R15 | C27 | C3 | coref-ident | the IL-2R Jak/STAT pathway;,the IL-2R-associated (Jak/STAT) pathway |
| R16 | C29 | C28 | coref-relat | which,T-cell immortalization mechanism(s) |
| R17 | C31 | C23 | coref-ident | rapamycin,rapamycin |
| R18 | C30 | C22 | coref-ident | rapamycin and RAD,rapamycin and its novel analog RAD |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 38-72 | protein_family_or_group | denotes | IL-2R associated JAK/STAT proteins |
| T2 | 143-168 | cell_type | denotes | uncultured leukemic cells |
| T3 | 174-182 | multi_cell | denotes | patients |
| T4 | 188-218 | other_name | denotes | adult T-cell lymphoma/leukemia |
| T5 | 258-263 | protein_molecule | denotes | IL-2R |
| T6 | 276-284 | protein_family_or_group | denotes | Jak/STAT |
| T7 | 301-322 | cell_line | denotes | HTLV-I infected cells |
| T8 | 336-360 | other_name | denotes | tyrosine phosphorylation |
| T9 | 364-368 | protein_molecule | denotes | Jak3 |
| T10 | 370-375 | protein_molecule | denotes | STAT3 |
| T11 | 381-386 | protein_molecule | denotes | STAT5 |
| T12 | 398-420 | cell_line | denotes | HTLV-I(+) T-cell lines |
| T13 | 428-455 | cell_type | denotes | uncultured leukemic T cells |
| T14 | 470-478 | multi_cell | denotes | patients |
| T15 | 484-514 | other_name | denotes | adult T-cell lymphoma/leukemia |
| T16 | 516-520 | other_name | denotes | ATLL |
| T17 | 561-565 | protein_molecule | denotes | Jak3 |
| T18 | 580-585 | protein_molecule | denotes | STAT3 |
| T19 | 590-595 | protein_molecule | denotes | STAT5 |
| T20 | 621-625 | protein_molecule | denotes | IL-2 |
| T21 | 682-686 | protein_molecule | denotes | IL-2 |
| T22 | 769-773 | protein_molecule | denotes | Jak3 |
| T23 | 778-783 | protein_molecule | denotes | STAT5 |
| T24 | 791-805 | cell_type | denotes | leukemic cells |
| T25 | 811-815 | other_name | denotes | ATLL |
| T26 | 816-824 | multi_cell | denotes | patients |
| T27 | 880-884 | protein_molecule | denotes | IL-2 |
| T28 | 897-901 | protein_molecule | denotes | Jak3 |
| T29 | 906-911 | protein_molecule | denotes | STAT5 |
| T30 | 936-944 | cell_type | denotes | leukemic |
| T31 | 945-949 | other_name | denotes | ATLL |
| T32 | 960-964 | protein_molecule | denotes | IL-2 |
| T33 | 1009-1026 | protein_molecule | denotes | SHP-1 phosphatase |
| T34 | 1060-1077 | protein_family_or_group | denotes | cytokine receptor |
| T35 | 1106-1110 | protein_molecule | denotes | IL-2 |
| T36 | 1164-1168 | other_name | denotes | ATLL |
| T37 | 1195-1217 | cell_line | denotes | HTLV-I(+) T-cell lines |
| T38 | 1245-1267 | cell_line | denotes | HTLV-I(-) T-cell lines |
| T39 | 1286-1295 | other_organic_compound | denotes | rapamycin |
| T40 | 1317-1320 | other_organic_compound | denotes | RAD |
| T41 | 1343-1349 | virus | denotes | HTLV-I |
| T42 | 1388-1416 | other_name | denotes | constitutive phosphorylation |
| T43 | 1424-1428 | protein_molecule | denotes | Jak3 |
| T44 | 1430-1435 | protein_molecule | denotes | STAT3 |
| T45 | 1441-1446 | protein_molecule | denotes | STAT5 |
| T46 | 1512-1516 | other_name | denotes | ATLL |
| T47 | 1568-1572 | protein_molecule | denotes | IL-2 |
| T48 | 1600-1605 | protein_molecule | denotes | IL-2R |
| T49 | 1606-1614 | protein_family_or_group | denotes | Jak/STAT |
| T50 | 1663-1695 | other_name | denotes | T-cell immortalization mechanism |
| T51 | 1723-1728 | protein_molecule | denotes | SHP-1 |
| T52 | 1754-1763 | other_organic_compound | denotes | rapamycin |
| T53 | 1768-1771 | other_organic_compound | denotes | RAD |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 490-505 | HP_0012190 | denotes | T-cell lymphoma |
| T2 | 490-514 | HP_0005517 | denotes | T-cell lymphoma/leukemia |
| T3 | 497-505 | HP_0002665 | denotes | lymphoma |
| T4 | 506-514 | HP_0001909 | denotes | leukemia |